IMMX Message Board | Immix Biopharma Inc.

znewcar1: $IMMX 24% v3,1M c2.30 f13,898M H2.39 ML1.51

cruzak · 2023-04-27

IMMX Message Board | Immix Biopharma Inc. znewcar1: $IMMX 24% v3,1M c2.30 f13,898M H2.39 ML1.51

Subject	By	Source	When
znewcar1: $IMMX 24% v3,1M c2.30 f13,898M H2.39 ML1.51	znewcar1	investorshangout	04/27/2023 8:46:40 PM
Thank you, bro, this one needs a pin	subslover	investorshub	04/27/2023 9:43:09 AM
$IMMX 5:30 NEWS https://finance.yahoo.com/news/nexcella-immix-biopharma-subsidiar	TheFinalCD	investorshub	04/26/2023 9:56:46 PM
N excella, an Immix Biopharma subsidiary, Announces Positive	Awl416	investorshub	04/26/2023 9:33:44 PM
Play the volume spikes an thats it or	harry crumb	investorshub	03/29/2023 2:00:43 PM
This wont move much for the next 18	harry crumb	investorshub	03/29/2023 2:00:14 PM
News	Awl416	investorshub	03/23/2023 12:01:53 PM
These are cheap	harry crumb	investorshub	03/10/2023 6:53:45 PM
Cant hurt to add more here at 2	harry crumb	investorshub	03/09/2023 12:49:56 PM
Another buying opp. Here	harry crumb	investorshub	02/28/2023 1:43:59 PM
Ditto harry. :)	subslover	investorshub	02/23/2023 2:52:21 AM
Here to $$$$	harry crumb	investorshub	02/22/2023 10:18:36 PM
Picking up some $MOJO!	subslover	investorshub	02/22/2023 2:22:07 PM
Added more 2.20s	harry crumb	investorshub	02/18/2023 4:18:04 AM
Still adding this ticker	harry crumb	investorshub	02/16/2023 2:15:43 AM
2.50 adding here	harry crumb	investorshub	02/13/2023 4:30:56 PM
$IMMX........................................https://stockcharts.com/h-sc/ui?s=IM	glenn1919	investorshub	02/10/2023 9:24:29 PM
$38M mkt cap.	IPO$	investorshub	02/10/2023 3:09:56 PM
Ton of cash here.	IPO$	investorshub	02/10/2023 3:07:55 PM
Pulled back	harry crumb	investorshub	02/07/2023 11:02:46 PM

Stock Information

Get IMMX Alerts

News, Short Squeeze, Breakout and More Instantly...

Immix Biopharma Inc. Company Name:

IMMX Stock Symbol:

NASDAQ Market:

IMMX - Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit

LOS ANGELES, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”) a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announc...
IMMX - Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted CAR-T Cell Therapy Candidate NXC-201 for Relapsed/Refractory AL Amyloidosis

LOS ANGELES, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq:IMMX) (“ImmixBio”, “Company”, “We” or “Us”), a clinical-stage biopharmaceutical company advancing personalized therapies for oncology and immunology, today announce...
IMMX - Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing

NEXICART-2 to expand studies of NXC-201 in relapsed/refractory AL Amyloidosis to U.S. sites based on IND clearance 72 patients previously dosed with NXC-201 ex-U.S. First CAR-T program for light-chain (AL) Amyloidosis Favorable tolerability enables expansion into autoimmune indication...